NASDAQ$COO

The Cooper Companies Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Cooper reported a strong start to fiscal 2022 with revenue increasing 16% year-over-year.

CooperCompanies announced strong first quarter results with revenue up 16% year-over-year to $787.2 million. CooperVision revenue increased by 11% and CooperSurgical revenue increased by 30%. GAAP diluted earnings per share were $1.91, while non-GAAP diluted earnings per share were $3.24, a 2% increase from the previous year.

  • Revenue increased 16% year-over-year to $787.2 million.
  • CooperVision revenue was up 11% to $561.5 million.
  • CooperSurgical revenue was up 30% to $225.7 million.
  • Non-GAAP diluted earnings per share were $3.24, up 2% from last year's first quarter.

Headline financials

Total Revenue

$787M

Previous: $681M+15.7%
EPS (adj)

$0.81

Previous: $0.79+2.5%
GAAP Gross Margin

66.0%

Previous: 66.0%+0.0%
GAAP Operating Margin

17.0%

Previous: 20.0%-15.0%
Capital Expenditures

-$57.1M

Previous: -$55.9M-2.1%
Free Cash Flow

$109M

Previous: $91.8M+18.6%
Net Income

$95.3M

Previous: $2.1B-95.5%
Operating Income

$131M

Previous: $133M-1.9%
Gross Profit

$518M

Previous: $451M+15.0%
Cash & Equivalents

$281M

Previous: $119M+135.7%
Total Assets

$11.7B

Previous: $8.92B+30.7%

Revenue & EPS history

Cooper · Revenue · Quarterly

$787M

Q1 2022+15.7%vs Q1 2021
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Cooper · $226M total across 2 segments · Q1 2022

  • Office and Surgical
    $129M+24.5%
  • Fertility
    $96.8M+38.3%

Forward guidance

Fiscal Year 2022 total revenue is expected to be $3,261 - $3,329 million with organic growth of 6.5% to 8.5%. CVI revenue is expected to be $2,221 - $2,264 million with organic growth of 7% to 9%. CSI revenue is expected to be $1,040 - $1,065 million with organic growth of 5% to 7%. Fiscal 2022 non-GAAP diluted EPS is expected to be $13.70 - $14.20.

Tailwinds

  • Fiscal 2022 total revenue $3,261 - $3,329 million (organic growth of 6.5% to 8.5%)
  • CVI revenue $2,221 - $2,264 million (organic growth of 7% to 9%)
  • CSI revenue $1,040 - $1,065 million (organic growth of 5% to 7%)
  • Fiscal 2022 non-GAAP diluted EPS $13.70 - $14.20

Headwinds

  • The continuing COVID-19 pandemic presents ongoing global risks to our markets and businesses.
  • The recent outbreak of war in Ukraine present ongoing global risks to our markets and businesses.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.5%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-0.1%

Avg return

30 days after

51%

35 / 68 earnings

Positive

+12.1%

Q3 2024

Best reaction

-12.8%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.6%-8.0%-12.5%
Q4 2025-4.3%+4.8%+5.3%
Q3 2025-12.8%-11.8%-8.9%
Q2 2025+0.0%-0.3%+3.6%
Q1 2025-6.6%-13.1%-18.9%
Q4 2024-6.0%-5.6%-12.6%
Q3 2024+12.1%+12.1%+16.4%
Q2 2024+3.5%+3.8%-4.2%
Q1 2024+8.1%+7.3%+7.4%
Q4 2023-2.2%-0.7%+6.8%
Q3 2023-2.1%-3.5%-15.9%
Q2 2023-4.0%-5.1%+3.2%
Q1 2023+8.7%+3.9%+15.4%
Q4 2022-1.6%+4.8%+9.7%
Q3 2022+4.1%+2.5%-8.5%
Q2 2022-0.3%+1.3%-7.2%
Q1 2022+2.1%-8.5%+3.1%
Q4 2021+4.8%+8.7%+12.2%
Q3 2021+1.1%-0.7%-7.6%
Q2 2021-0.7%-3.2%+6.0%
Q1 2021+1.8%+0.3%+1.1%
Q4 2020+3.3%+3.3%+8.6%
Q3 2020+2.0%+0.3%+5.7%
Q2 2020-0.2%-5.0%-9.1%
Q1 2020-1.3%-0.9%-17.3%
Q4 2019-1.6%-2.4%+3.3%
Q3 2019-3.5%-6.7%-8.3%
Q2 2019+4.5%+9.0%+18.2%
Q1 2019-1.8%+0.1%+1.0%
Q4 2018-11.6%-7.3%-10.4%
Q3 2018-3.7%-3.4%+4.3%
Q2 2018+1.4%-0.4%+6.0%
Q1 2018+2.1%-3.8%-11.5%
Q4 2017-3.2%-1.9%-1.5%
Q3 2017-4.0%-2.5%-3.7%
Q2 2017+8.9%+10.5%+9.4%
Q1 2017-3.1%-3.6%-0.4%
Q4 2016+1.3%+4.1%+5.2%
Q3 2016+0.0%+1.3%-3.6%
Q2 2016-0.1%-0.4%+7.1%
Q1 2016+6.4%
Q4 2015-12.8%
Q3 2015-7.1%
Q2 2015-5.1%
Q1 2015+9.7%
Q4 2014-4.4%
Q3 2014+0.7%
Q2 2014+1.7%
Q1 2014+4.3%
Q4 2013-4.6%
Q3 2013-1.8%
Q2 2013+8.1%
Q1 2013+2.5%
Q4 2012+1.0%
Q3 2012+10.3%
Q2 2012-4.1%
Q1 2012+2.8%
Q4 2008+2.8%
Q4 2011+2.8%
Q3 2011-1.8%
Q2 2011+1.4%
Q2 2010+1.4%
Q1 2010+8.9%
Q1 2011+1.0%
Q4 2010-1.5%
Q3 2010+5.8%
Q3 2009+5.8%
Q4 2009+5.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro